Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 2, 2010, Pages 273-275

  Kheirandish, P ^a   Seyedalinaghi, S A ^a   Hosseini, M ^b   Jahani, M R ^c   Shirzad, H ^d   Foroughi, M ^a   Ahmadian, M R Seyed ^d   Jabbari, H ^a   Mohraz, M ^a   McFarland, W ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Baghiyatallah University   (Iran)

^d Research Center Head Quarter of Police Force Medicine   (Iran)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV; Injection drug users; Iran; Prevalence; Risk factors

Indexed keywords

OPIATE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; DRUG MISUSE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; MAJOR CLINICAL STUDY; MALE; POLICE; PRIORITY JOURNAL; PRISON; QUESTIONNAIRE; SCREENING TEST;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; IRAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 75649096721     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181be6dde     Document Type: Article

References (22)

1. UNAIDS Update 2004. Islamic Republic of Iran: Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Disease. Available at: http://data.unaids.org/Publications/Fact-Sheets01/iran-en.pdf. Accessed May 12, 2005 and January 7, 2007.
2. Gouya MM. National Report on HIV and AIDS Cases. Tehran, Iran: Disease Management Center, Ministry of Health and Medical Education, 2008.
3. Khani M, Vakili MM. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Zanjan prisoners. Arch Iranian Med. 2003;6:1-4.
4. Miller M, Mella I, Moi H, et al. HIV and hepatitis c virus risk in new and longer-term injecting drug users in Oslo, Norway. JAIDS. 2003;33: 373-379.
5. Kate Dolan K, Kite B, Black E, et al. HIV in prison in low-income and middle-income countries. Lancet Infect Dis. 2007;7:32-41.
6. Rowhani Rahbar A, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUS) in Mashhad, Iran. Int J Drug Policy. 2004;15:151-155.
7. Zamani S, Kihara M, Gouya MM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS. 2005;19:709-716
8. Razzaghi EM, Rahimia Movaghar A, Craig Green T, et al. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J. 2006;3:12.
9. Jahani MR, Kheirandish P, Hosseini M, et al. HIV seroconversion among injection drug users in detention, Tehran, Iran. AIDS. 2009;23:538-540.
10. Nassirimanesh B, Trace M, Roberts M. The rise of harm reduction in the Islamic Republic of Iran. Briefing Paper Eight. Oxford, UK: The Beckley Foundation Drug Policy Programme, 2005.
11. Zamani S, Kihara M, Gouya, MM, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquire Immune Defic Synd. 2006;42:342-346.
12. March JC, Oviedo-Joekes E, Romero M. Factors associated with reported hepatitis C and HIV among injecting drug users in ten European cities. Enferm Infecc Microbiol Clin. 2007;25:91-97.
13. Wodak A, Cooney A. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users, World Health Organization Evidence for Action Technical Papers. Geneva: World Health Organization, 2004.
14. Beyrer C, Jittiwutikarn J, Teokul W, et al. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav. 2003;7:153-161.
15. UNAIDS. AIDS epidemic update December 2002. Geneva: UNAIDS, 2002.
16. Adjei AA, Armah HB, Gbagbo F, et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: a national multicenter study. BMC Infect Dis. 2008;8:33.
17. Taylor A, Goldberg D, Emslie J, et al. Outbreak of HIV infection in a Scottish prison. BMJ. 1995;310:289-292.
18. Dolan K, Wodak A. HIV transmission in a prison system in an Australian state. Med J Aust. 1999;171:14-17.
19. Day C, Nassirimanesh B, Shakeshaft A, et al. Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J. 2006;3:2.
20. Rehm J, Betteridge G, Stöver H, et al. Prison Needle Exchange: Lessons from a Comprehensive Review of the International Evidence and Experience. Montreal: Canadian HIV/AIDS Legal Network, 2004.
21. Eshrati B, Taghizadeh Asl R, Anne Dell C, et al. Preventing HIV transmission among Iranian prisoners: Initial support for providing education on the benefits of harm reduction practices. Harm Reduct J. 2008;5:21.
22. Hajiabdolbaghi M, Razani N, Karami N, et al. Insights from a survey of sexual behavior among a group of at-risk women in Tehran, Iran, 2006. AIDS Educ Prevent. 2007;19:519-530.